Philip N Patsalos Selected Research

Philip N Patsalos Research Topics

Disease

34	Epilepsy (Aura) 01/2022 - 04/2002
17	Seizures (Absence Seizure) 01/2016 - 04/2002
7	Drug Resistant Epilepsy 12/2013 - 02/2002
3	Dizziness (Lightheadedness) 12/2013 - 01/2011
3	Status Epilepticus (Complex Partial Status Epilepticus) 11/2004 - 02/2003
2	Generalized Epilepsy 01/2016 - 01/2005
2	Headache (Headaches) 12/2013 - 04/2012
2	Fatigue 12/2013 - 04/2012
2	Sleepiness 12/2013 - 04/2012
2	Partial Epilepsies (Epilepsy, Partial) 12/2013 - 04/2012
2	Diplopia (Double Vision) 04/2012 - 01/2011
2	Trigeminal Neuralgia (Tic Douloureux) 05/2003 - 02/2002
1	Lennox Gastaut Syndrome 01/2020
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020
1	Nausea 04/2012
1	Coronary Disease (Coronary Heart Disease) 02/2008
1	Acute Kidney Injury (Acute Renal Failure) 02/2003
1	Cardiac Arrhythmias (Arrythmia) 02/2003
1	Pain (Aches) 02/2002

Drug/Important Bio-Agent (IBA)

28	Anticonvulsants (Antiepileptic Drugs)IBA 03/2020 - 04/2002
12	Pharmaceutical PreparationsIBA 03/2020 - 04/2002
12	Levetiracetam (Keppra)FDA LinkGeneric 01/2019 - 02/2002
8	Valproic Acid (Depakote)FDA LinkGeneric 01/2010 - 04/2002
7	Lacosamide FDA Link 08/2014 - 08/2010
7	Lamotrigine (Lamictal)FDA LinkGeneric 12/2013 - 04/2002
7	Phenytoin (Dilantin)FDA LinkGeneric 02/2013 - 02/2002
6	Carbamazepine (Tegretol)FDA LinkGeneric 02/2013 - 02/2002
6	Phenobarbital (Luminal)FDA Link 02/2013 - 12/2005
5	Topiramate (Topamax)FDA LinkGeneric 12/2013 - 11/2004
5	Oxcarbazepine (Trileptal)FDA LinkGeneric 12/2013 - 02/2002
5	Ethosuximide (Zarontin)FDA LinkGeneric 02/2013 - 01/2005
5	Pentylenetetrazole (Metrazol)IBA 11/2009 - 12/2005
4	perampanelIBA 01/2016 - 12/2013
4	Gabapentin (Neurontin)FDA LinkGeneric 12/2013 - 10/2008
4	Zonisamide (Zonegran)FDA LinkGeneric 12/2013 - 01/2005
4	Clonazepam (Rivotril)FDA LinkGeneric 11/2009 - 01/2005
3	Tiagabine (Gabitril)FDA Link 12/2013 - 03/2009
3	Vigabatrin FDA Link 12/2013 - 10/2008
2	EnzymesIBA 01/2020 - 01/2020
2	stiripentolIBA 12/2013 - 11/2006
2	eslicarbazepine acetateIBA 12/2013 - 04/2012
2	ezogabine (retigabine)IBA 12/2013 - 04/2012
2	Biomarkers (Surrogate Marker)IBA 02/2013 - 10/2010
2	Clobazam (HR 376)IBA 02/2013 - 01/2005
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2008 - 09/2005
1	CannabidiolIBA 01/2020
1	SolutionsIBA 01/2020
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2016
1	Excitatory Amino Acid AntagonistsIBA 01/2016
1	AcidsIBA 01/2016
1	Pregabalin (Lyrica)FDA Link 12/2013
1	Felbamate (Felbatol)FDA Link 12/2013
1	rufinamide FDA Link 12/2013
1	Primidone (Sertan)FDA LinkGeneric 02/2013
1	Sodium Channels (Sodium Channel)IBA 01/2012
1	Caffeine (No Doz)FDA LinkGeneric 09/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2008
1	Eicosapentaenoic AcidIBA 02/2008
1	Docosahexaenoic AcidsIBA 02/2008
1	remacemideIBA 08/2007
1	loreclezoleIBA 12/2005
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2004
1	Drug CombinationsIBA 11/2004
1	budipineIBA 11/2004
1	N-Methylaspartate (NMDA)IBA 11/2004
1	AlbuminsIBA 02/2003
1	Charcoal (Charbon)IBA 02/2003
1	talampanelIBA 01/2003
1	Baclofen FDA LinkGeneric 02/2002

Therapy/Procedure

8	Therapeutics 01/2016 - 04/2002
2	Drug Tapering 01/2011 - 02/2002
1	Drug Substitution 01/2022
1	Subcutaneous Injections 03/2009
1	Drug Therapy (Chemotherapy) 05/2003
1	Microvascular Decompression Surgery 02/2002